Skip to main content

14 October 2025

Last updated: Sunday 12 October 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Cystic fibrosis: one mutation down, more to come

Friday 14 September 2012

Interviewee/Contributor

Eric Olson

Organisation

Vertex Pharmaceuticals Inc

Organisations

Intercell AG
Alzheimer's Drug Discovery Foundation
DCPrime BV
AgomAb Therapeutics NV
DeepVerge Plc
Alnylam Pharmaceuticals Inc
Marks & Clerk Solicitors LLP
TreeFrog Therapeutics SAS
Verona Pharma Plc
Index Ventures

Interviewees and Contributers

Marisa Papaluca-Amati
Karen Finn
Jan Fagerberg
Kevin Johnson
Julian Hitchcock
Robert Burns
Max Hasmann
Alexander Gebauer
Neelam Patel
Ralf Schmid and Emma Harvey

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

CHARM Therapeutics appoints CMO

Tuesday 16 September 2025

Abzena appoints CEO

Tuesday 16 September 2025

OMass Therapeutics appoints director

Tuesday 16 September 2025

Maxion Therapeutics appoints non-executive director

Tuesday 16 September 2025

AlzeCure Pharma appoints head of development

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form